The End of Diabetes: The Eat to Live Plan to Prevent and Reverse Diabetes

<!–ACNTP

Provia Labs, LLC today reported that it has formed a working group to recommend the company on the best way to promote industry standards in the preservation of stem cells from teeth. The meeting is being held April 27-29 in NY City at the Big Apple Academy of Sciences, hosted by Columbia University’s University of Dental Medicine. In addition, Provia Laboratories offers dental stem cell banking through its Store-A-Tooth234 ; brand in the U.S. And has begun collaborating with companies in India and a few Latin American nations to provide dental stem cell preservation worldwide.

“Research into dental stem cells is now a worldwide enterprise,” said Peter Verlander, Ph.D, chief scientific officer at Provia Laboratories. “We think this research will result in broad medical and dental benefits as findings in the lab lead directly to new cures in everyday practice, making regenerative dentistry and medication the standard of care.” . “As this potential becomes more apparent, we think that many families will need to bank their children’s dental stem cells-cells that become available when baby teeth fall out or wisdom teeth are extracted. So the time is now to make sure that all facilities entrusted with preserving dental stem cell samples are operating at industry-recognized standards.” . The Quality Advisory Group will guide Provia Labs on drafting laws for the collection, transport, processing and storage of dental stem cells, including suitable quality-control metrics to help guarantee industry-wide uniformity in the viability and utility of these cells. The working group will also advise Provia Laboratories on how best to seek industry acceptance and adoption of the suggested standards.

The original members of the working group are :

• Joseph C. Laning, Ph.D. Doctor. Laning is the senior director of the Human Stem Cell Bank and Registry at the College of Massachusetts Medical School. He has also held research positions at Amaranth Bio Inc. And Organogenesis.

  Dr . Laning earned his Ph.D. In Immunology from Harvard College.

• Paul T. Sharpe, Ph.D. Doctor. Sharpe is the Dickinson Professor of Craniofacial Biology and the director of analysis at the Dental Institute, King’s School London. His research interests include molecular control over craniofacial hard-tissue morphogenesis, dental stem cells, and stem-cell-based tissue engineering of teeth and bone. He and his associates received the 2006 William J. Gies Award for best paper printed in the Book of Dental Research during the preceding year in the category of biomaterials and bioengineering.

  He holds a Ph.D. Degree in biochemistry from Sheffield College.

• Peter C. Verlander, Ph.D. Dr. Verlander is a molecular geneticist with virtually 15 years of expertise in human-genetics research in both academia and industry.

  Before joining Provia Laboratories, he was the associate director for Strategic Development at the Lab for Molecular Medicine in the Harvard Medical College – Partners Healthcare Center for Genetics and Genomics. He led the team that developed the first clinical test for identification of EGFR mutations predicting healing response in lung adenocarcinoma. He got his Ph.D. In Microbiology from Duke Varsity.

• Mervin Yoder, M.D. Doctor. Yoder is the Richard and Pauline Klingler Professor of Pediatrics and Professor of Molecular Biology and Biochemistry at the Indiana University School of Medicine, where he was given his M.D. Degree.

  He finished a residency programme in Pediatrics and a fellowship in Neonatal-Perinatal Medicine at The Children’s Surgery of Philadelphia, and he's the co-author of a textbook on the handling of critically ill newborns. His research interests have concentrated on the temporal and spatial emergence of hematopoietic and endothelial cells in the mouse embryo. His lab has helped define endothelial progenitor cells in human subjects. He's past President of the ISEH Society for Hematology and Stem Cells.

Dr . Verlander commented, “We suspect the standard of our Store-A-Tooth service is unsurpassed regarding the techniques we use to ensure proper collection, transport, processing and storage of dental stem cells.* Provia’s mission is to supply the very best quality repository for our customers – safeguarding the stem cells from their family’s teeth for potential use in times to come.

We however recognize that technology is usually evolving, and we plan to stay at the advance guard in dental stem cell preservation. We are also hopeful that the advice of this working group will prove helpful to others who attempt to realize the prospects of dental stem cells for regenerative medicine and dentistry.” . In two thousand, analysts at the U.S. Countrywide Institutes of Health demonstrated that teeth are a source of stem cells, with the potentiality to distinguish into diverse specialised cell types. Stem cells from teeth have just been used in human studies to regrow jawbone and treat periodontal disease.

Research into wide-ranging medical applications is early, but promising. Dental stem cells are being studied for their potential in therapies for type one diabetes, spinal-cord injury, heart attack and stroke, corneal damage, and neurodegenerative anomalies like Parkinson’s disease. Frequently the donors of dental stem cells are youngsters and kids, since it is an straightforward process to gather samples when a baby tooth is ready to fall out or a back tooth needs to be extracted. The tooth should be taken out by a dental professional to keep its blood supply untouched. After removing the tooth, the dentist or oral surgeon places it into a kit designed to defend the tooth during overnite transport to the cell-preservation facility. There the sample is decontaminated and tested to confirm its sterility, and the dental pulp is harvested.

QC tests like flow cytometry are performed to affirm that stem cell biomarkers are found to be present in the examples. The examples are then stored at extremely low temperatures for the potential benefit of donors in future years as stem-cell treatments become more readily available. About Provia Laboratories LLC . Provia Laboratories, LLC (provialabs) is a medical care services company based near Boston, Massachusetts which makes a speciality of prime quality biobanking (preservation of biological specimens). The company recommends industrial, academic, and government clients on matters related to the protection of biological samples for research and clinical use. Additionally, Provia offers a variety of products for use in complex biobanking environments to improve sample logistics, security, and quality.

Provia Labs is a member of ISBER, the International Society for Biological and Environmental Repositories. *The Store-A-Tooth facility is registered by the US Food and Drug Administration and compliant with FDA guidelines relevant to human cells and tissue products ; certificated under CLIA (the Clinical Laboratory Improvement Amendments) ; approved by the state health departments of New York, Massachusetts, and California ; and accredited by the North American Association of Blood Banks (AABB). For the details about Store-A-Tooth dental stem cell preservation, try calling 1-877-867-5753 or visit store-a-tooth press release distribution

ACNTPEND–>

The End of Diabetes: The Eat to Live Plan to Prevent and Reverse Diabetes